Srinivas Teppala

7PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingNeurogeneticsMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Cost-effectiveness of first-line pembrolizumab monotherapy in PD-L1-high metastatic non-small cell lung cancer in Australia: evidence from trials and real-world practice.

|Apr 08, 2026
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison.

Srinivas Teppala, Juhee Koo, Stephen Clarke

|Jan 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?

Kim Edmunds, Shiksha Arora, Sri Teppala

|Mar 05, 2024
The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer.

Srinivas Teppala, Paul A Scuffham, Haitham Tuffaha

|Nov 25, 2022
A review of the cost-effectiveness of genetic testing for germline variants in familial cancer.

Srinivas Teppala, Brent Hodgkinson, Sandi Hayes

|Jan 25, 2019
Profiles of vocalization change in children with autism receiving early intervention.

David Trembath, Marleen F Westerveld, Srinivas Teppala

Pageof 2

Frequent Collaborators

3 joint publications

Paul Scuffham

3 joint publications

Haitham Tuffaha

2 joint publications

Christine Y Lu

2 joint publications

Stephen Clarke